Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorXi'an No.3 Hospital
About this trial
Objective: To observe the practical application of the standardized green channel treatment system for stroke in Xi 'an in the real world. Methods: Clinical data and information of patients with acute ischemic stroke who received standardized green channel treatment for stroke were collected, and a multicenter observational clinical study was carried out in the real world to evaluate the prognosis, mortality, incidence of asymptomatic and symptomatic cerebral hemorrhage, incidence of pneumonia, and recurrence rate of stroke after 90 days.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years old;
Consistent with the diagnosis of acute ischemic stroke;
24 hours from onset to enrollment;
Informed consent
Disqualifiers
Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis);
Stroke patients caused by brain tumor, brain trauma and blood diseases;
Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke;
Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination;
Trial population
Patients with acute ischemic stroke within 24 hours of onset; Receive standardized green channel treatment for stroke
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Standardized green channel treatment methods for stroke
Other interventionThe measures include six measures: timely triage by triage desk nurses; Rapid evaluation by emergency room physician; If stroke is suspected, the green channel for nosocomial stroke should be activated immediately. Stroke greenway doctors and stroke nurses accompanied patients to complete CT examination; Intravenous thrombolysis in emergency rooms or CT rooms; Suspected macrovascular disease, if the onset time is less than 6 hours, quickly go to the catheter room for intravascular treatment; If the onset time was more than 6 hours, multi-mode imaging was used to quickly evaluate the ischemic penumbra and vascular occlusion, and then the patients were sent to the catheter room for intravascular treatment as soon as possible.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Rate of function independent
Rate of modified Rankin Scale(mRS) score less than 3 at 90 days
Time frame
90 days after onsetSecondary outcomes
1
Rate of mortality
90-day mortality rate
Time frame
90 days after onset2
Rate of stroke recurrence
90-day stroke recurrence rate
Time frame
90 days after onset3
Rate of cerebral hemorrhage and pneumonia
Incidence of cerebral hemorrhage and pneumonia after thrombolysis or intravascular therapy
Time frame
During hospitalization.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov